Rowan Announces $2.1M to Build Machine Learning-Powered Computational Tools for Chemistry
Summary
BOSTON, Dec. 9, 2024 Rowan, a company building molecular design and simulation tools for scientists, today announced $2.1 million in pre-seed funding. "Modern algorithms and machine learning models can dramatically accelerate scientific R&D by replacing resource-intensive experiments," said Corin Wagen, PhD, CEO and founder of Rowan. "As Rowan helps more scientists use modern computational techniques, our company will accelerate the speed of scientific progress across drug discovery and materials science. ""Today, biotech and pharma companies can invest hundreds of millions of dollars developing a single drug, and conventional simulations struggle to accelerate this process," said Tony Kulesa, partner at Pillar VC. "Rowan is building the next generation of powerful computational tools to save these companies an extraordinary amount of time and money as they advance their research.